<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2018.9034</article-id>
<article-id pub-id-type="publisher-id">mmr-18-01-0882</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>RNA-sequencing analysis of aberrantly expressed long non-coding RNAs and mRNAs in a mouse model of ventilator-induced lung injury</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Xu</surname><given-names>Bo</given-names></name>
<xref rid="af1-mmr-18-01-0882" ref-type="aff">1</xref>
<xref rid="af2-mmr-18-01-0882" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yizhou</given-names></name>
<xref rid="af3-mmr-18-01-0882" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Xiujuan</given-names></name>
<xref rid="af1-mmr-18-01-0882" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Mao</surname><given-names>Yanfei</given-names></name>
<xref rid="af2-mmr-18-01-0882" ref-type="aff">2</xref>
<xref rid="c2-mmr-18-01-0882" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Deng</surname><given-names>Xiaoming</given-names></name>
<xref rid="af1-mmr-18-01-0882" ref-type="aff">1</xref>
<xref rid="c1-mmr-18-01-0882" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-18-01-0882"><label>1</label>Department of Anesthesiology and Intensive Care, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China</aff>
<aff id="af2-mmr-18-01-0882"><label>2</label>Department of Anesthesiology and SICU, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, P.R. China</aff>
<aff id="af3-mmr-18-01-0882"><label>3</label>Department of Hepatic Surgery IV, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-18-01-0882"><italic>Correspondence to</italic>: Professor Xiaoming Deng, Department of Anesthesiology and Intensive Care, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai 200433, P.R. China, E-mail: <email>deng_x@yahoo.com</email></corresp>
<corresp id="c2-mmr-18-01-0882">Professor Yanfei Mao, Department of Anesthesiology and SICU, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, 1665 Kongjiang Road, Shanghai 200092, P.R. China, E-mail: <email>maoyanfei@xinhuamed.com.cn</email></corresp>
</author-notes>
<pub-date pub-type="ppub"><month>07</month><year>2018</year></pub-date>
<pub-date pub-type="epub"><day>17</day><month>05</month><year>2018</year></pub-date>
<volume>18</volume>
<issue>1</issue>
<fpage>882</fpage>
<lpage>892</lpage>
<history>
<date date-type="received"><day>07</day><month>11</month><year>2017</year></date>
<date date-type="accepted"><day>22</day><month>03</month><year>2018</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Xu et al.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Long non-coding RNAs (lncRNAs) are closely associated with the regulation of various biological processes and are involved in the pathogenesis of numerous diseases. However, to the best of our knowledge, the role of lncRNAs in ventilator-induced lung injury (VILI) has yet to be evaluated. In the present study, high-throughput sequencing was applied to investigate differentially expressed lncRNAs and mRNAs (fold change &#x003E;2; false discovery rate &#x003C;0.05). Bioinformatics analysis was employed to predict the functions of differentially expressed lncRNAs. A total of 104 lncRNAs (74 upregulated and 30 downregulated) and 809 mRNAs (521 upregulated and 288 downregulated) were differentially expressed in lung tissues from the VILI group. Gene ontology analysis demonstrated that the differentially expressed lncRNAs and mRNAs were mainly associated with biological functions, including apoptosis, angiogenesis, neutrophil chemotaxis and skeletal muscle cell differentiation. The top four enriched pathways were the tumor necrosis factor (TNF) signaling pathway, P53 signaling pathway, neuroactive ligand-receptor interaction and the forkhead box O signaling pathway. Several lncRNAs were predicted to serve a vital role in VILI. Subsequently, three lncRNAs [mitogen-activated protein kinase kinase 3, opposite strand (Map2k3os), dynamin 3, opposite strand and abhydrolase domain containing 11, opposite strand] and three mRNAs (growth arrest and DNA damage-inducible &#x03B1;, claudin 4 and thromboxane A2 receptor) were measured by reverse transcription-quantitative polymerase chain reaction, in order to confirm the veracity of RNA-sequencing analysis. In addition, Map2k3os small interfering RNA transfection inhibited the expression of stretch-induced cytokines [TNF-&#x03B1;, interleukin (IL)-1&#x03B2; and IL-6] in MLE12 cells. In conclusion, the results of the present study provided a profile of differentially expressed lncRNAs in VILI. Several important lncRNAs may be involved in the pathological process of VILI, which may be useful to guide further investigation into the pathogenesis for this disease.</p>
</abstract>
<kwd-group>
<kwd>long non-coding RNA</kwd>
<kwd>RNA-sequencing analysis</kwd>
<kwd>ventilator-induced lung injury</kwd>
<kwd>mouse</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Mechanical ventilation (MV) is an irreplaceable therapy for patients in intensive care units and emergency departments. Although the techniques for MV have significantly improved in the past 20 years (<xref rid="b1-mmr-18-01-0882" ref-type="bibr">1</xref>), the risk of aggravating lung injury in patients with acute respiratory distress syndrome (ARDS) (<xref rid="b2-mmr-18-01-0882" ref-type="bibr">2</xref>), and damaging healthy lung tissue, remains (<xref rid="b3-mmr-18-01-0882" ref-type="bibr">3</xref>,<xref rid="b4-mmr-18-01-0882" ref-type="bibr">4</xref>). Lung injury caused by MV is also known as ventilator-induced lung injury (VILI), and is characterized by tissue disruption, lung edema and pulmonary inflammation (<xref rid="b5-mmr-18-01-0882" ref-type="bibr">5</xref>&#x2013;<xref rid="b7-mmr-18-01-0882" ref-type="bibr">7</xref>). A recent study from the ARDS Network indicated that VILI may increase the mortality of critically ill patients by ~10&#x0025; (<xref rid="b8-mmr-18-01-0882" ref-type="bibr">8</xref>). However, in addition to the protective pulmonary ventilation strategy, there are few specific treatments for VILI, as the potential mechanism remains poorly understood. Therefore, it is imperative to identify the pathogenesis of VILI to provide an experimental foundation for clinical treatment.</p>
<p>In the transcriptome, numerous protein-coding mRNAs, as well as non-protein coding transcripts, are closely associated with the pathogenesis of several diseases. Long non-coding RNAs (lncRNAs) are defined as non-protein coding transcripts &#x003E;200 nucleotides long (<xref rid="b9-mmr-18-01-0882" ref-type="bibr">9</xref>). In recent years, a growing body of evidence has indicated that lncRNAs are involved in various important biological processes, including proliferation (<xref rid="b10-mmr-18-01-0882" ref-type="bibr">10</xref>), apoptosis (<xref rid="b11-mmr-18-01-0882" ref-type="bibr">11</xref>), brain development (<xref rid="b12-mmr-18-01-0882" ref-type="bibr">12</xref>,<xref rid="b13-mmr-18-01-0882" ref-type="bibr">13</xref>), inflammation (<xref rid="b14-mmr-18-01-0882" ref-type="bibr">14</xref>,<xref rid="b15-mmr-18-01-0882" ref-type="bibr">15</xref>) and immunoregulation (<xref rid="b16-mmr-18-01-0882" ref-type="bibr">16</xref>,<xref rid="b17-mmr-18-01-0882" ref-type="bibr">17</xref>), leading to numerous diseases (<xref rid="b18-mmr-18-01-0882" ref-type="bibr">18</xref>&#x2013;<xref rid="b20-mmr-18-01-0882" ref-type="bibr">20</xref>); lncRNAs may therefore provide alternative targets for the treatment of these diseases (<xref rid="b19-mmr-18-01-0882" ref-type="bibr">19</xref>,<xref rid="b21-mmr-18-01-0882" ref-type="bibr">21</xref>).</p>
<p>Although the crucial roles of lncRNAs have been investigated in numerous diseases, to the best of the authors&#x0027; knowledge, no study has been conducted to investigate the profile and function of lncRNAs in VILI. In the present study, differentially expressed lncRNAs and mRNAs were investigated by high-throughput sequencing, and bioinformatics analysis was employed to predict their functions in VILI.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Animals</title>
<p>Experiments were performed on 16 male ICR mice (age, 7&#x2013;9 weeks, 25&#x2013;30 g; Shanghai SLAC Laboratory Animal Co., Shanghai, China). Mice were housed in a temperature-controlled room (22&#x00B1;2&#x00B0;C) under a 12-h light/dark cycle, and were provided <italic>ad libitum</italic> access to food and water. The humidity was maintained at 50&#x2013;60&#x0025;. All experimental protocols and animal handling procedures were approved by the Ethics Committee on Experimental Animals of Shanghai Jiaotong University School of Medicine (Shanghai, China). Mice were divided into two groups: Sham-operated group and VILI group (n=8/group). A total of eight pairs of right lungs were used for RNA-sequencing (RNA-Seq) analysis, whereas eight pairs of left lungs were used for reverse transcription-quantitative polymerase chain reaction (RT-qPCR).</p>
</sec>
<sec>
<title>Establishment of a VILI mouse model</title>
<p>Following anesthesia with 100 mg/kg ketamine and 8 mg/kg xylazine (intraperitoneal), mice were fixed in a supine position, endotracheal intubation was performed and the tube was connected to a rodent ventilator (Inspira; Harvard Apparatus Ltd., Holliston, MA, USA). Ventilation was performed at a tidal volume of 30 ml/kg and a respiratory rate of 70 breaths/min for 4 h as previously described (<xref rid="b22-mmr-18-01-0882" ref-type="bibr">22</xref>,<xref rid="b23-mmr-18-01-0882" ref-type="bibr">23</xref>). Mice in the sham group underwent intubation but were allowed to breathe freely. Gas with fraction of inspired oxygen at 21&#x0025; was used, and the inspiratory/expiratory ratio was 2:1. At the end of the experiment, animals were sacrificed by anesthetic overdose and the lung tissues were harvested for further investigation.</p>
</sec>
<sec>
<title>RNA-Seq analysis</title>
<p>Total RNA was extracted from lung tissues in the VILI and sham groups with TRIzol<sup>&#x00AE;</sup> (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA), according to the manufacturer&#x0027;s protocol. RNA concentration was determined using NanoDrop 2000 (NanoDrop; Thermo Fisher Scientific, Inc., Wilmington, DE, USA), and RNA quality was evaluated with Bioanalyzer 2200 (Agilent Technologies, Inc., Santa Clara, CA, USA) and by 1&#x0025; agarose gel electrophoresis. RNA with RNA integrity number &#x003E;8.0 was used to construct a cDNA library. A total of five pair of lungs met the criterion and were used for RNA-Seq analysis.</p>
<p>The cDNA libraries were subsequently constructed with Ion Total RNA-Seq kit version 2.0 (Thermo Fisher Scientific, Inc.). Subsequently, proton sequencing was performed using the cDNA libraries and Ion PI Sequencing 200 kit version 2.0 (Thermo Fisher Scientific, Inc.), according to the manufacturer&#x0027;s protocol. Briefly, samples were mixed and processed on the Ion OneTouch 2 System (Thermo Fisher Scientific, Inc.). Subsequently, they were enriched on the OneTouch 2 ES station for the preparation of template-positive Ion PI Ion Sphere Particles. Finally, the mixed samples were loaded onto 1 P1v2 Proton Chip (Thermo Fisher Scientific, Inc.) for sequencing. Data analysis was performed by NovelBio Bio-Pharm Technology Co., Ltd. (Shanghai, China).</p>
</sec>
<sec>
<title>RNA-seq mapping and identification of differentially expressed genes</title>
<p>The Mapsplice v2.2.0 program was used for RNA-seq data mapping (<xref rid="b24-mmr-18-01-0882" ref-type="bibr">24</xref>). Per kilobase per million was used to measure the expression level of each gene (<xref rid="b25-mmr-18-01-0882" ref-type="bibr">25</xref>). The expression of different genes between two groups was evaluated with the EB-Seq (<xref rid="b26-mmr-18-01-0882" ref-type="bibr">26</xref>) algorithm. When the absolute fold change (FC) was &#x003E;2 and the false discovery rate (FDR) was &#x003C;0.05, the gene was defined as differentially expressed (<xref rid="b26-mmr-18-01-0882" ref-type="bibr">26</xref>).</p>
</sec>
<sec>
<title>Gene ontology (GO) and pathway analysis</title>
<p>GO analysis was performed to analyze the biological functions of differentially expressed genes (<xref rid="b27-mmr-18-01-0882" ref-type="bibr">27</xref>). GO annotations were obtained from gene in NCBI (<uri xlink:href="https://www.ncbi.nlm.nih.gov/gene/">https://www.ncbi.nlm.nih.gov/gene/</uri>) and the Gene Ontology (<uri xlink:href="http://www.geneontoloy.org/">http://www.geneontoloy.org/</uri>). Kyoto Encyclopedia of Genes and Genomics (KEGG) database (<uri xlink:href="http://www.genome.jp.kegg/">http://www.genome.jp.kegg/</uri>) was employed to analyze the pathways associated with these differentially expressed genes (<xref rid="b28-mmr-18-01-0882" ref-type="bibr">28</xref>). In addition, differentially expressed genes enriched in &#x2265;2 biological pathways were selected to build the &#x2018;path-act network&#x2019; a graphical representation of pathways of the interaction of these pathway terms using cytoscape 3.5.1 (<xref rid="b29-mmr-18-01-0882" ref-type="bibr">29</xref>).</p>
</sec>
<sec>
<title>Gene co-expression network analysis</title>
<p>Gene co-expression network analysis, analyzed by R software 3.3.3, was employed to predict the key lncRNAs that function in the important biological processes and signal transduction pathways based on the correlation between differentially expressed lncRNAs and mRNAs (<xref rid="b30-mmr-18-01-0882" ref-type="bibr">30</xref>). The significant correlation pairs (Pearson&#x0027;s correlation coefficient &#x003E;0.95) were selected to build the network. The core regulatory genes were determined by k-core scoring in the network (<xref rid="b31-mmr-18-01-0882" ref-type="bibr">31</xref>). The k-core indicates the hub or nodal status of a gene having interactions with other genes in the network. The higher the k-core score of a gene, the more central the gene location in the gene co-expression network.</p>
</sec>
<sec>
<title>RT-qPCR analysis</title>
<p>To confirm the veracity of RNA-Seq analysis, the expression of three lncRNAs and three mRNAs was measured by RT-qPCR using the SYBR-Green method (FastStart Universal SYBR Master; Roche Diagnostics, Basel, Switzerland) and a MiniOpticon real-time PCR detection system (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Total RNA was extracted from lung tissues using TRIzol<sup>&#x00AE;</sup> reagent (Invitrogen; Thermo Fisher Scientific, Inc.) and cDNA was synthesized (RevertAid First Strand cDNA Synthesis kit; Thermo Fisher Scientific, Inc.) with the reaction conditions: 25&#x00B0;C 10 min, 42&#x00B0;C 1 h, 72&#x00B0;C 10 min and 4&#x00B0;C hold. All of the primers (<xref rid="tI-mmr-18-01-0882" ref-type="table">Table I</xref>) used for RT-qPCR were designed and synthesized by Sangon Biotech Co., Ltd. (Shanghai, China). PCR was performed under the following conditions: Predenaturation for 2 min at 95&#x00B0;C with cycle, denaturation for 15 sec at 95&#x00B0;C, annealing for 15 sec at 60&#x00B0;C and extension for 1 min at 72&#x00B0;C with 40 cycles from denaturation to extension. The expression of each gene was calculated using the 2<sup>&#x2212;&#x0394;&#x0394;Cq</sup> (<xref rid="b32-mmr-18-01-0882" ref-type="bibr">32</xref>) method and normalized to that of &#x03B2;-actin. The experiments were repeated twice.</p>
</sec>
<sec>
<title>Cell culture and treatment</title>
<p>To determine the function of differentially expressed lncRNAs, the effects of Map2k3os were measured on the release of inflammatory cytokines from alveolar epithelial cells induced by cyclic stretch. The MLE12 [Obio Technology (Shanghai) Corp., Ltd., Shanghai, China] murine lung epithelial cell line was cultured with Dulbecco&#x0027;s modified Eagle&#x0027;s medium (HyClone; GE Healthcare Life Sciences, Logan, UT, USA) supplemented with 10&#x0025; fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.) at 37&#x00B0;C in an atmosphere containing 5&#x0025; CO<sub>2</sub> (<xref rid="b33-mmr-18-01-0882" ref-type="bibr">33</xref>). Map2k3os small interfering RNA (siRNA) was synthesized by Shanghai GenePharma Co., Ltd. (Shanghai, China), as was the negative control siRNA. The sequence of mouse Map2k3os siRNA was: 5&#x2032;-CCCAUGGGAAGCAAAGCAATT-3&#x2032;. The sequence of negative control siRNA was: 5&#x2032;-UUCUCCGAACGUGUCACGUTT-3&#x2032;. MLE-12 cells were seeded onto Collagen I-coated Bioflex 6-well culture plates (BFI products, Inc., Hollywood, FL, USA). When the cells reached 80&#x0025; coverage of one well, they were transfected with siRNA (60 pmol/ml) using Xfect siRNA transfection reagents (Takara Bio, Inc., Otsu, Japan). Following transfection for 24 h, the medium was renewed and the cells were subjected to cyclic stretch (20&#x0025; linear elongation, sinusoidal wave, 30 cycles/min) for 4 h, as previously described (<xref rid="b34-mmr-18-01-0882" ref-type="bibr">34</xref>), using the Flexcell-FX-5,000 Tension system (Flexcell International Corporation, Burlington, NC, USA). Control cells were placed in the same culture plates and incubated next to the stretched cells at 37&#x00B0;C in an atmosphere containing 5&#x0025; CO<sub>2</sub>. Following cyclic stretch, the cells were harvested to analyze the expression of interleukin (IL)-1&#x03B2;, IL-6 and tumor necrosis factor (TNF)-&#x03B1; by RT-qPCR conducted as previously described in the RT-qPCR subsection. The primer sequences (Sangon Biotech Co., Ltd.) were as follows: IL-1&#x03B2; forward, 5&#x2032;-TCGCAGCAGCACATCAACAAGAG-3&#x2032; and reverse, 5&#x2032;-TGCTCATGTCCTCATCCTGGAAGG-3&#x2032;; IL-6 forward, 5&#x2032;-ACTTCCATCCAGTTGCCTTCTTGG-3&#x2032; and reverse, 5&#x2032;-TTAAGCCTCCGACTTGTGAAGTGG-3&#x2032;; and TNF-&#x03B1; forward, 5&#x2032;-GCGACGTGGAACTGGCAGAAG-3&#x2032; and reverse, 5&#x2032;-GCCACAAGCAGGAATGAGAAGAGG-3&#x2032;.</p>
</sec>
<sec>
<title>ELISA</title>
<p>Following cyclic stretch, the conditioned medium was collected. IL-1&#x03B2; (cat. no. F10770), IL-6 (cat. no. F10830) and TNF-&#x03B1; (cat. no. F11630) concentrations were determined using ELISA kits (Shanghai Westang Biotechnology Co., Ltd., Shanghai, China) for mice, according to the manufacturer&#x0027;s protocols.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All data were analyzed with SPSS version 20.0 (IBM Corp., Armonk, NY, USA). Student&#x0027;s t-test was applied to identify the differently expressed lncRNAs and mRNAs following RNA-Seq and RT-qPCR. According to previous studies (<xref rid="b35-mmr-18-01-0882" ref-type="bibr">35</xref>,<xref rid="b36-mmr-18-01-0882" ref-type="bibr">36</xref>), Fisher&#x0027;s exact test and &#x03C7;<sup>2</sup> test were used to examine the significance of GO category and pathway analysis. FDR was used to correct the multiple testing to minimize the error of P-value (<xref rid="b37-mmr-18-01-0882" ref-type="bibr">37</xref>,<xref rid="b38-mmr-18-01-0882" ref-type="bibr">38</xref>), and in RNA-Seq to identify the differentially expressed genes (FDR&#x003C;0.05). One-way analysis of variance followed by Dunnett&#x0027;s test for multiple comparisons was use to compare the difference between multiple groups. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Differentially expressed lncRNAs and mRNAs</title>
<p>LncRNA and mRNA expression between the VILI and sham groups was analyzed using the DE-Seq algorithm, and differentially expressed genes were identified. A total of 104 lncRNAs and 809 mRNAs were identified as differentially expressed between the groups by high-throughput sequencing. Among the 104 lncRNAs, 74 were upregulated and 30 were downregulated. Of the 809 mRNAs, 521 were upregulated and 288 were downregulated. Volcano plot was used to identify differentially expressed genes (lncRNAs and mRNAs) between the two groups; when the expression was similar, the genes were marked blue, whereas the differentially expressed genes (FC&#x003E;2 and FDR&#x003C;0.05) were marked red (<xref rid="f1-mmr-18-01-0882" ref-type="fig">Fig. 1</xref>). The top 20 differentially expressed genes are presented in <xref rid="tII-mmr-18-01-0882" ref-type="table">Table II</xref> (10 upregulated and 10 downregulated lncRNAs). To validate the results from RNA-Seq, the expression levels of three lncRNAs (Map2k3os, Dnm3os and Abhd11os) and three mRNAs (Gadd45a, Cldn4 and Tbxa2r) were detected by RT-qPCR. The results demonstrated that the change in the expression of these lncRNAs and mRNAs determined by RT-qPCR was similar to that from RNA-Seq (<xref rid="f2-mmr-18-01-0882" ref-type="fig">Fig. 2A and B</xref>).</p>
</sec>
<sec>
<title>GO analysis</title>
<p>GO analysis indicated that the differentially expressed mRNAs were associated with numerous important biological processes, cellular components and molecular functions. The present study indicated that 189 GO terms (147 upregulated and 42 downregulated) associated with biological processes were enriched (P&#x003C;0.01, FDR&#x003C;0.05). The primary upregulated GO categories were mainly involved in cell apoptosis, neutrophil chemotaxis, inflammatory response, cell proliferation and response to glucocorticoid (<xref rid="f3-mmr-18-01-0882" ref-type="fig">Fig. 3A</xref>), whereas the downregulated categories were mainly associated with the positive regulation of transcription (DNA-templated), cell-cell signaling, cellular response to interferon-&#x03B3;, cell cycle and positive regulation of cytosolic calcium concentration (<xref rid="f3-mmr-18-01-0882" ref-type="fig">Fig. 3B</xref>).</p>
</sec>
<sec>
<title>Pathway enrichment analysis</title>
<p>The pathway enrichment analysis was employed to investigate the pathways associated with important differentially expressed genes. -Lg P-value was used to describe the significance level of pathway enrichment. There were 60 upregulated pathways and 21 downregulated pathways. The top 20 differentially expressed pathways with upregulated expression were mainly associated with the TNF, hypoxia-inducible factor (HIF)-1, p53 and Forkhead box O signaling pathways, and those with downregulated expression were associated with neuroactive ligand-receptor interaction, Hippo signaling pathway, phenylalanine metabolism and calcium signaling pathway (<xref rid="f4-mmr-18-01-0882" ref-type="fig">Fig. 4A</xref>). The differentially expressed genes in these pathways provide evidence for further investigations of the potential mechanisms underlying the pathogenesis of VILI. The interactions between these pathways are illustrated in <xref rid="f4-mmr-18-01-0882" ref-type="fig">Fig. 4B</xref>.</p>
</sec>
<sec>
<title>LncRNA-mRNA co-expression network</title>
<p>LncRNA-mRNA co-expression network was constructed based on the differentially expressed genes detected between the VILI and sham group lung tissues. There were 182 network nodes and 509 connections between genes in the VILI group. In this co-expression network, 272 pairs had positive association and 237 pairs exhibited negative association (<xref rid="f5-mmr-18-01-0882" ref-type="fig">Fig. 5</xref>). The properties of the constructed gene networks were determined by k-cores and the degree of differences. In the co-expression network, lncRNAs with differential degree &#x2265;10 and k-core &#x2265;8 included RIKEN cDNA 4933407K13 gene (4933407K13Rik), RIKEN cDNA E230013L22 gene (E230013L22Rik), RIKEN cDNA 3010003L21 gene (3010003L21Rik), RIKEN cDNA A330009N23 gene (A330009N23Rik), protein D930048N14Rik (D930048N14Rik), predicted gene 11827 (Gm11827) and predicted gene 10872 (Gm10872). The top 20 differentially expressed lncRNAs, as determined by the gene co-expression analysis, are presented in <xref rid="tIII-mmr-18-01-0882" ref-type="table">Table III</xref>. These differentially expressed lncRNAs may be responsible for the potential mechanism underlying VILI.</p>
</sec>
<sec>
<title>Effects of Map2k3os siRNA on inflammatory cytokine release from MLE12 cells</title>
<p>Compared with in the control cells, it was identified that Map2k3os siRNA decreased the expression of Map2k3os by 89&#x0025;, as determined by RT-qPCR (<xref rid="tIV-mmr-18-01-0882" ref-type="table">Table IV</xref>). Cyclic stretch significantly increased the mRNA expression levels of TNF-&#x03B1;, IL-1&#x03B2; and IL-6 in MLE12 cells, and protein levels in the supernatants. Conversely, Map2k3os siRNA transfection inhibited the expression of these stretch-induced cytokines (<xref rid="f6-mmr-18-01-0882" ref-type="fig">Fig. 6</xref>). These results indicated the effects of Map2k3os on epithelial secretion of cytokines in cyclic stretch-induced VILI.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>In the present study, RNA-Seq analysis identified 104 lncRNAs and 809 mRNAs, which were differentially expressed in lung tissues between the VILI group and the sham group. Bioinformatics analysis predicted several lncRNAs that were likely to alter the transcription of related mRNAs, and thus participate in the development of VILI. To the best of the authors&#x0027; knowledge, the present study is the first to analyze the function of lncRNAs in VILI using high-throughput sequencing and bioinformatics analysis.</p>
<p>At present, there have been few studies regarding the transcriptomics of VILI (<xref rid="b39-mmr-18-01-0882" ref-type="bibr">39</xref>&#x2013;<xref rid="b41-mmr-18-01-0882" ref-type="bibr">41</xref>). These previous studies used microarray analysis, and to the best of the authors&#x0027; knowledge, a previous study tested the lncRNAs. Ma <italic>et al</italic> (<xref rid="b39-mmr-18-01-0882" ref-type="bibr">39</xref>) focused on early stress response genes in rodents (mouse and rat) following VILI, and identified 41 upregulated genes and 7 downregulated genes in the injured lungs. GO analysis revealed that these genes may be involved in cell cycle arrest, immune response, inflammatory response, blood coagulation, chemotaxis, apoptosis, cell-cell signaling and negative regulation of cell proliferation (<xref rid="b39-mmr-18-01-0882" ref-type="bibr">39</xref>). Another study (<xref rid="b40-mmr-18-01-0882" ref-type="bibr">40</xref>) only reported inflammasome-related gene expression, including IL-1&#x03B1;, caspase-activator domain-10, and IL-1 receptor-1 and &#x2212;2. Furthermore, a previous study (<xref rid="b41-mmr-18-01-0882" ref-type="bibr">41</xref>) used microarray analysis to identify the effects of non-muscle myosin light chain kinase isoform on VILI. This study also identified alterations in the expression of several genes in VILI, including thioredoxin domain-containing 9, C-X-C motif chemokine ligand 2 and MYB proto-oncogene, transcription factor. As in previous studies, all of the biological processes reported and the majority of genes identified were also observed in the present study. The difference in the differentially expressed genes among available studies is possibly ascribed to the difference in species (mouse and rat vs. mouse) and methodology (microarray vs. high-throughput sequencing). In the present study, not only mRNAs, but also lncRNAs, were analyzed in the lung tissues, and GO analysis, pathway enrichment analysis, and lncRNA-mRNA co-expression networks were employed to predict the function of lncRNAs. Therefore, the findings may provide evidence regarding the mechanism underlying VILI and aid the development of novel targets to treat VILI.</p>
<p>The onset of VILI is associated with several biological processes and signaling pathways. MV can damage the lungs by direct mechanical injury and indirectly via the induction of biotrauma. Several signaling pathways and mRNAs identified in the present study have been identified in previous studies. Hyperinflation of mouse lungs <italic>in vivo</italic> and <italic>in vitro</italic> can induce the expression of nuclear factor (NF)-&#x03BA;B and IL-6 in alveolar macrophages and alveolar epithelial type II cells (<xref rid="b42-mmr-18-01-0882" ref-type="bibr">42</xref>). In addition, chemokines [chemokine (C-X-C motif) ligand 1, cytokine-induced neutrophil chemoattractant-2&#x03B1; and macrophage inflammatory protein 2 (MIP-2)] and their receptors are activated during lung injury (<xref rid="b43-mmr-18-01-0882" ref-type="bibr">43</xref>). The neutrophil elastase inhibitor sivelestat is able to inhibit neutrophil accumulation, and decrease the release of MIP-2, IL-6 and TNF-&#x03B1; in VILI mice (<xref rid="b44-mmr-18-01-0882" ref-type="bibr">44</xref>). The present study also confirmed the important role of inflammatory response, neutrophil chemotaxis and the NF-&#x03BA;B signaling pathway. In addition, apoptosis was identified as the first key biological process in VILI by high-throughput sequencing. Previous studies also identified that pathological cyclic stretch could induce pulmonary epithelial apoptosis and barrier dysfunction in alveolar epithelial cells (<xref rid="b45-mmr-18-01-0882" ref-type="bibr">45</xref>,<xref rid="b46-mmr-18-01-0882" ref-type="bibr">46</xref>). Conversely, a previous study reported that ventilation at low tidal volumes results in a mild inflammatory response without increasing apoptosis, which is accompanied by accelerated alveolar epithelial cell proliferation (<xref rid="b47-mmr-18-01-0882" ref-type="bibr">47</xref>). This differs from the results of the present study, which may be ascribed to the low tidal volume used in the previous study.</p>
<p>KEGG pathway analysis in the present study also demonstrated that several signaling pathways were associated with the pathogenesis of VILI. TNF is able to regulate pulmonary alveolar permeability, alveolar fluid clearance, adhesion molecule expression and leucocyte recruitment (<xref rid="b48-mmr-18-01-0882" ref-type="bibr">48</xref>). TNF has been identified as a marker of early activation of inflammation and can be rapidly released in response to cyclic stretch (<xref rid="b49-mmr-18-01-0882" ref-type="bibr">49</xref>,<xref rid="b50-mmr-18-01-0882" ref-type="bibr">50</xref>). In addition, HIF-1 can promote transcription of A2B adenosine receptor (A2BAR), whereas deletion of the A2BAR gene could reduce survival time and increase pulmonary albumin leakage following VILI (<xref rid="b51-mmr-18-01-0882" ref-type="bibr">51</xref>,<xref rid="b52-mmr-18-01-0882" ref-type="bibr">52</xref>). Furthermore, although the specific role of the P53 signaling pathway in VILI has not been reported, microarray assay has revealed it is involved in the pathogenesis of VILI (<xref rid="b41-mmr-18-01-0882" ref-type="bibr">41</xref>). In the present study, a number of genes were differentially expressed between the sham group and the VILI group. Some genes have been verified by previous studies (<xref rid="b49-mmr-18-01-0882" ref-type="bibr">49</xref>,<xref rid="b53-mmr-18-01-0882" ref-type="bibr">53</xref>), whereas others may be novel targets with which to explore the mechanisms of VILI.</p>
<p>In the lncRNA-mRNA co-expression network, 4933407K13Rik, E230013L22Rik, 3010003L21Rik, A330009N23Rik, D930048N14Rik, Gm11827 and Gm10872 were most likely to be responsible for the potential mechanism underlying VILI. These lncRNAs may directly and indirectly regulate the transcription of related mRNAs, thus participating in the development of VILI. The top 20 differentially expressed lncRNAs are main target genes for future study. The present study confirmed that transfection with siRNA targeting Map2k3os (one of the top 20 lncRNAs) inhibited stretch-induced cytokine (TNF-&#x03B1;, IL-1&#x03B2; and IL-6) expression in MLE12 cells. However, further experiments are required to study the detailed function and mechanism of these lncRNAs in VILI. In addition, next-generation sequencing technology itself has certain limitations, including flux, which means the number of RNA samples that can be measured by a sequenator at the same time, is not high enough and the length of RNA reads remains relatively short (<xref rid="b54-mmr-18-01-0882" ref-type="bibr">54</xref>), which may be improved with the development of improved technology.</p>
<p>In conclusion, the present study provided novel information regarding the lncRNAs, signaling pathways and the co-expression network involved in VILI. Numerous significant lncRNAs are likely to participate in the pathogenesis of VILI, which may be useful to guide further research into the mechanisms and targeted therapy for this disease.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors wish to thank Dr Yan Wang and Dr Chufan Xu (Department of Anesthesiology and SICU, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine) for their technical assistance.</p>
</ack>
<sec>
<title>Funding</title>
<p>The present study was supported by grants from the National Natural Science Foundation of China (grant nos. 81100826, 81372100 and 81772108).</p>
</sec>
<sec>
<title>Availability of data and materials</title>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>All authors participated in study design of the research question. BX contributed to model building, performing the ELISA and writing the manuscript. YW helped to perform RT-qPCR and analyze data. XL performed cell culture and statistics. YM and XD mainly designed the research and revised the manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>All experimental protocols and animal handling procedures were approved by the Ethics Committee on Experimental Animals of Shanghai Jiaotong University School of Medicine (Shanghai, China).</p>
</sec>
<sec>
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-mmr-18-01-0882"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brower</surname><given-names>RG</given-names></name><name><surname>Fessler</surname><given-names>HE</given-names></name></person-group><article-title>Mechanical ventilation in acute lung injury and acute respiratory distress syndrome</article-title><source>Clin Chest Med</source><volume>21</volume><issue>491&#x2013;510</issue><fpage>viii</fpage><year>2000</year></element-citation></ref>
<ref id="b2-mmr-18-01-0882"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belperio</surname><given-names>JA</given-names></name><name><surname>Keane</surname><given-names>MP</given-names></name><name><surname>Lynch</surname><given-names>JP</given-names><suffix>III</suffix></name><name><surname>Strieter</surname><given-names>RM</given-names></name></person-group><article-title>The role of cytokines during the pathogenesis of ventilator-associated and ventilator-induced lung injury</article-title><source>Semin Respir Crit Care Med</source><volume>27</volume><fpage>350</fpage><lpage>364</lpage><year>2006</year><pub-id pub-id-type="doi">10.1055/s-2006-948289</pub-id><pub-id pub-id-type="pmid">16909369</pub-id></element-citation></ref>
<ref id="b3-mmr-18-01-0882"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neto</surname><given-names>AS</given-names></name><name><surname>Simonis</surname><given-names>FD</given-names></name><name><surname>Barbas</surname><given-names>CS</given-names></name><name><surname>Biehl</surname><given-names>M</given-names></name><name><surname>Determann</surname><given-names>RM</given-names></name><name><surname>Elmer</surname><given-names>J</given-names></name><name><surname>Friedman</surname><given-names>G</given-names></name><name><surname>Gajic</surname><given-names>O</given-names></name><name><surname>Goldstein</surname><given-names>JN</given-names></name><name><surname>Linko</surname><given-names>R</given-names></name><etal/></person-group><article-title>Lung-protective ventilation with low tidal volumes and the occurrence of pulmonary complications in patients without acute respiratory distress syndrome: A systematic review and individual patient data analysis</article-title><source>Crit Care Med</source><volume>43</volume><fpage>2155</fpage><lpage>2163</lpage><year>2015</year><pub-id pub-id-type="doi">10.1097/CCM.0000000000001189</pub-id><pub-id pub-id-type="pmid">26181219</pub-id></element-citation></ref>
<ref id="b4-mmr-18-01-0882"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neto</surname><given-names>Serpa A</given-names></name><name><surname>Hemmes</surname><given-names>SN</given-names></name><name><surname>Barbas</surname><given-names>CS</given-names></name><name><surname>Beiderlinden</surname><given-names>M</given-names></name><name><surname>Biehl</surname><given-names>M</given-names></name><name><surname>Binnekade</surname><given-names>JM</given-names></name><name><surname>Canet</surname><given-names>J</given-names></name><name><surname>Fernandez-Bustamante</surname><given-names>A</given-names></name><name><surname>Futier</surname><given-names>E</given-names></name><name><surname>Gajic</surname><given-names>O</given-names></name><etal/></person-group><article-title>Protective versus conventional ventilation for surgery: A systematic review and individual patient data meta-analysis</article-title><source>Anesthesiology</source><volume>123</volume><fpage>66</fpage><lpage>78</lpage><year>2015</year><pub-id pub-id-type="doi">10.1097/ALN.0000000000000706</pub-id><pub-id pub-id-type="pmid">25978326</pub-id></element-citation></ref>
<ref id="b5-mmr-18-01-0882"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>WI</given-names></name><name><surname>Quinn</surname><given-names>DA</given-names></name><name><surname>Park</surname><given-names>KM</given-names></name><name><surname>Moufarrej</surname><given-names>RK</given-names></name><name><surname>Jafari</surname><given-names>B</given-names></name><name><surname>Syrkina</surname><given-names>O</given-names></name><name><surname>Bonventre</surname><given-names>JV</given-names></name><name><surname>Hales</surname><given-names>CA</given-names></name></person-group><article-title>Systemic microvascular leak in an in vivo rat model of ventilator-induced lung injury</article-title><source>Am J Respir Crit Care Med</source><volume>167</volume><fpage>1627</fpage><lpage>1632</lpage><year>2003</year><pub-id pub-id-type="doi">10.1164/rccm.200210-1216OC</pub-id><pub-id pub-id-type="pmid">12663326</pub-id></element-citation></ref>
<ref id="b6-mmr-18-01-0882"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slutsky</surname><given-names>AS</given-names></name><name><surname>Ranieri</surname><given-names>VM</given-names></name></person-group><article-title>Ventilator-induced lung injury</article-title><source>N Engl J Med</source><volume>369</volume><fpage>2126</fpage><lpage>2136</lpage><year>2013</year><pub-id pub-id-type="doi">10.1056/NEJMra1208707</pub-id><pub-id pub-id-type="pmid">24283226</pub-id></element-citation></ref>
<ref id="b7-mmr-18-01-0882"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Ge</surname><given-names>YL</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>XZ</given-names></name><name><surname>Yuan</surname><given-names>YP</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>SQ</given-names></name></person-group><article-title>miR-127 contributes to ventilator-induced lung injury</article-title><source>Mol Med Rep</source><volume>16</volume><fpage>4119</fpage><lpage>4126</lpage><year>2017</year><pub-id pub-id-type="doi">10.3892/mmr.2017.7109</pub-id><pub-id pub-id-type="pmid">28765901</pub-id></element-citation></ref>
<ref id="b8-mmr-18-01-0882"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brower</surname><given-names>RG</given-names></name><name><surname>Lanken</surname><given-names>PN</given-names></name><name><surname>MacIntyre</surname><given-names>N</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Morris</surname><given-names>A</given-names></name><name><surname>Ancukiewicz</surname><given-names>M</given-names></name><name><surname>Schoenfeld</surname><given-names>D</given-names></name><name><surname>Thompson</surname><given-names>BT</given-names></name></person-group><article-title>National Heart, Lung, and Blood Institute ARDS Clinical Trials Network: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome</article-title><source>N Engl J Med</source><volume>351</volume><fpage>327</fpage><lpage>336</lpage><year>2004</year><pub-id pub-id-type="doi">10.1056/NEJMoa032193</pub-id><pub-id pub-id-type="pmid">15269312</pub-id></element-citation></ref>
<ref id="b9-mmr-18-01-0882"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Oliver</surname><given-names>PL</given-names></name><name><surname>Reik</surname><given-names>W</given-names></name></person-group><article-title>Evolution and functions of long noncoding RNAs</article-title><source>Cell</source><volume>136</volume><fpage>629</fpage><lpage>641</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.cell.2009.02.006</pub-id><pub-id pub-id-type="pmid">19239885</pub-id></element-citation></ref>
<ref id="b10-mmr-18-01-0882"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>JC</given-names></name><name><surname>Hu</surname><given-names>XF</given-names></name></person-group><article-title>Long non-coding RNA HOXA11-AS promotes cell proliferation and metastasis in human breast cancer</article-title><source>Mol Med Rep</source><volume>16</volume><fpage>4887</fpage><lpage>4894</lpage><year>2017</year><pub-id pub-id-type="doi">10.3892/mmr.2017.7163</pub-id><pub-id pub-id-type="pmid">28791375</pub-id></element-citation></ref>
<ref id="b11-mmr-18-01-0882"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name></person-group><article-title>LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma</article-title><source>Cell Death Dis</source><volume>8</volume><fpage>e2975</fpage><year>2017</year><pub-id pub-id-type="doi">10.1038/cddis.2017.358</pub-id><pub-id pub-id-type="pmid">28796257</pub-id><pub-id pub-id-type="pmcid">5596549</pub-id></element-citation></ref>
<ref id="b12-mmr-18-01-0882"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del&#x00E1;s</surname><given-names>MJ</given-names></name><name><surname>Hannon</surname><given-names>GJ</given-names></name></person-group><article-title>lncRNAs in development and disease: From functions to mechanisms</article-title><source>Open Biol</source><volume>7</volume><comment>pii: 170121</comment><year>2017</year><pub-id pub-id-type="doi">10.1098/rsob.170121</pub-id></element-citation></ref>
<ref id="b13-mmr-18-01-0882"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>C</given-names></name><name><surname>Deng</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Genome-wide analysis reveals extensive changes in LncRNAs during skeletal muscle development in Hu sheep</article-title><source>Genes (Basel)</source><volume>8</volume><comment>pii: E191</comment><year>2017</year><pub-id pub-id-type="doi">10.3390/genes8080191</pub-id></element-citation></ref>
<ref id="b14-mmr-18-01-0882"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>HJ</given-names></name><name><surname>Wei</surname><given-names>QF</given-names></name><name><surname>Wang</surname><given-names>SJ</given-names></name><name><surname>Zhang</surname><given-names>HJ</given-names></name><name><surname>Zhang</surname><given-names>XY</given-names></name><name><surname>Geng</surname><given-names>Q</given-names></name><name><surname>Cui</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>XH</given-names></name></person-group><article-title>LncRNA HOTAIR alleviates rheumatoid arthritis by targeting miR-138 and inactivating NF-&#x03BA;B pathway</article-title><source>Int Immunopharmacol</source><volume>50</volume><fpage>283</fpage><lpage>290</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.intimp.2017.06.021</pub-id><pub-id pub-id-type="pmid">28732288</pub-id></element-citation></ref>
<ref id="b15-mmr-18-01-0882"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>H</given-names></name><name><surname>Peng</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>LY</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>HM</given-names></name><name><surname>Liu</surname><given-names>HD</given-names></name><name><surname>Yu</surname><given-names>LJ</given-names></name><name><surname>Li</surname><given-names>AL</given-names></name><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>Jiang</surname><given-names>WH</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><article-title>LincRNA-Gm4419 knockdown ameliorates NF-&#x03BA;B/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy</article-title><source>Cell Death Dis</source><volume>8</volume><fpage>e2583</fpage><year>2017</year><pub-id pub-id-type="doi">10.1038/cddis.2016.451</pub-id><pub-id pub-id-type="pmid">28151474</pub-id><pub-id pub-id-type="pmcid">5386454</pub-id></element-citation></ref>
<ref id="b16-mmr-18-01-0882"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>L</given-names></name><name><surname>Ji</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Jia</surname><given-names>W</given-names></name><name><surname>Chu</surname><given-names>WM</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name></person-group><article-title>The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion</article-title><source>Nat Commun</source><volume>8</volume><fpage>15129</fpage><year>2017</year><pub-id pub-id-type="doi">10.1038/ncomms15129</pub-id><pub-id pub-id-type="pmid">28541302</pub-id><pub-id pub-id-type="pmcid">5529670</pub-id></element-citation></ref>
<ref id="b17-mmr-18-01-0882"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mumtaz</surname><given-names>PT</given-names></name><name><surname>Bhat</surname><given-names>SA</given-names></name><name><surname>Ahmad</surname><given-names>SM</given-names></name><name><surname>Dar</surname><given-names>MA</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name><name><surname>Urwat</surname><given-names>U</given-names></name><name><surname>Ayaz</surname><given-names>A</given-names></name><name><surname>Shrivastava</surname><given-names>D</given-names></name><name><surname>Shah</surname><given-names>RA</given-names></name><name><surname>Ganai</surname><given-names>NA</given-names></name></person-group><article-title>LncRNAs and immunity: Watchdogs for host pathogen interactions</article-title><source>Biol Proced Online</source><volume>19</volume><fpage>3</fpage><year>2017</year><pub-id pub-id-type="doi">10.1186/s12575-017-0052-7</pub-id><pub-id pub-id-type="pmid">28465674</pub-id><pub-id pub-id-type="pmcid">5406993</pub-id></element-citation></ref>
<ref id="b18-mmr-18-01-0882"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misawa</surname><given-names>A</given-names></name><name><surname>Takayama</surname><given-names>KI</given-names></name><name><surname>Inoue</surname><given-names>S</given-names></name></person-group><article-title>Long non-coding RNAs and prostate cancer</article-title><source>Cancer Sci</source><volume>108</volume><fpage>2107</fpage><lpage>2114</lpage><year>2017</year><pub-id pub-id-type="doi">10.1111/cas.13352</pub-id><pub-id pub-id-type="pmid">28796922</pub-id><pub-id pub-id-type="pmcid">5665759</pub-id></element-citation></ref>
<ref id="b19-mmr-18-01-0882"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haemmig</surname><given-names>S</given-names></name><name><surname>Simion</surname><given-names>V</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Feinberg</surname><given-names>MW</given-names></name></person-group><article-title>Long noncoding RNAs in cardiovascular disease, diagnosis, and therapy</article-title><source>Curr Opin Cardiol</source><volume>32</volume><fpage>776</fpage><lpage>783</lpage><year>2017</year><pub-id pub-id-type="doi">10.1097/HCO.0000000000000454</pub-id><pub-id pub-id-type="pmid">28786864</pub-id></element-citation></ref>
<ref id="b20-mmr-18-01-0882"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>YT</given-names></name><name><surname>Xu</surname><given-names>DY</given-names></name><name><surname>Wang</surname><given-names>GY</given-names></name><name><surname>Sun</surname><given-names>JL</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>SZ</given-names></name></person-group><article-title>IL-6 induced lncRNA MALAT1 enhances TNF-&#x03B1; expression in LPS-induced septic cardiomyocytes via activation of SAA3</article-title><source>Eur Rev Med Pharmacol Sci</source><volume>21</volume><fpage>302</fpage><lpage>309</lpage><year>2017</year><pub-id pub-id-type="pmid">28165557</pub-id></element-citation></ref>
<ref id="b21-mmr-18-01-0882"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahlestedt</surname><given-names>C</given-names></name></person-group><article-title>Targeting long non-coding RNA to therapeutically upregulate gene expression</article-title><source>Nat Rev Drug Discov</source><volume>12</volume><fpage>433</fpage><lpage>446</lpage><year>2013</year><pub-id pub-id-type="doi">10.1038/nrd4018</pub-id><pub-id pub-id-type="pmid">23722346</pub-id></element-citation></ref>
<ref id="b22-mmr-18-01-0882"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Wasserloos</surname><given-names>K</given-names></name><name><surname>Chao</surname><given-names>W</given-names></name><name><surname>Kaynar</surname><given-names>AM</given-names></name><name><surname>Liu</surname><given-names>ZQ</given-names></name><name><surname>Leikauf</surname><given-names>GD</given-names></name><name><surname>Pitt</surname><given-names>BR</given-names></name><name><surname>Zhang</surname><given-names>LM</given-names></name></person-group><article-title>Toll-like receptor 4-myeloid differentiation factor 88 signaling contributes to ventilator-induced lung injury in mice</article-title><source>Anesthesiology</source><volume>113</volume><fpage>619</fpage><lpage>629</lpage><year>2010</year><pub-id pub-id-type="pmid">20683250</pub-id><pub-id pub-id-type="pmcid">3726314</pub-id></element-citation></ref>
<ref id="b23-mmr-18-01-0882"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>LF</given-names></name><name><surname>Yang</surname><given-names>CT</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Liu</surname><given-names>YY</given-names></name><name><surname>Kao</surname><given-names>KC</given-names></name><name><surname>Lin</surname><given-names>HC</given-names></name></person-group><article-title>Low-molecular-weight heparin reduces hyperoxia-augmented ventilator-induced lung injury via serine/threonine kinase-protein kinase B</article-title><source>Respir Res</source><volume>12</volume><fpage>90</fpage><year>2011</year><pub-id pub-id-type="doi">10.1186/1465-9921-12-90</pub-id><pub-id pub-id-type="pmid">21726460</pub-id><pub-id pub-id-type="pmcid">3136419</pub-id></element-citation></ref>
<ref id="b24-mmr-18-01-0882"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Zeng</surname><given-names>Z</given-names></name><name><surname>Coleman</surname><given-names>SJ</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Savich</surname><given-names>GL</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Mieczkowski</surname><given-names>P</given-names></name><name><surname>Grimm</surname><given-names>SA</given-names></name><name><surname>Perou</surname><given-names>CM</given-names></name><etal/></person-group><article-title>MapSplice: Accurate mapping of RNA-seq reads for splice junction discovery</article-title><source>Nucleic Acids Res</source><volume>38</volume><fpage>e178</fpage><year>2010</year><pub-id pub-id-type="doi">10.1093/nar/gkq622</pub-id><pub-id pub-id-type="pmid">20802226</pub-id><pub-id pub-id-type="pmcid">2952873</pub-id></element-citation></ref>
<ref id="b25-mmr-18-01-0882"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortazavi</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>BA</given-names></name><name><surname>McCue</surname><given-names>K</given-names></name><name><surname>Schaeffer</surname><given-names>L</given-names></name><name><surname>Wold</surname><given-names>B</given-names></name></person-group><article-title>Mapping and quantifying mammalian transcriptomes by RNA-Seq</article-title><source>Nat Methods</source><volume>5</volume><fpage>621</fpage><lpage>628</lpage><year>2008</year><pub-id pub-id-type="doi">10.1038/nmeth.1226</pub-id><pub-id pub-id-type="pmid">18516045</pub-id></element-citation></ref>
<ref id="b26-mmr-18-01-0882"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><article-title>Differential expression analysis for sequence count data</article-title><source>Genome Biol</source><volume>11</volume><fpage>R106</fpage><year>2010</year><pub-id pub-id-type="doi">10.1186/gb-2010-11-10-r106</pub-id><pub-id pub-id-type="pmid">20979621</pub-id><pub-id pub-id-type="pmcid">3218662</pub-id></element-citation></ref>
<ref id="b27-mmr-18-01-0882"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M</given-names></name><name><surname>Ball</surname><given-names>CA</given-names></name><name><surname>Blake</surname><given-names>JA</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name><name><surname>Butler</surname><given-names>H</given-names></name><name><surname>Cherry</surname><given-names>JM</given-names></name><name><surname>Davis</surname><given-names>AP</given-names></name><name><surname>Dolinski</surname><given-names>K</given-names></name><name><surname>Dwight</surname><given-names>SS</given-names></name><name><surname>Eppig</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium</article-title><source>Nat Genet</source><volume>25</volume><fpage>25</fpage><lpage>29</lpage><year>2000</year><pub-id pub-id-type="doi">10.1038/75556</pub-id><pub-id pub-id-type="pmid">10802651</pub-id><pub-id pub-id-type="pmcid">3037419</pub-id></element-citation></ref>
<ref id="b28-mmr-18-01-0882"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Goto</surname><given-names>S</given-names></name><name><surname>Kawashima</surname><given-names>S</given-names></name><name><surname>Okuno</surname><given-names>Y</given-names></name><name><surname>Hattori</surname><given-names>M</given-names></name></person-group><article-title>The KEGG resource for deciphering the genome</article-title><source>Nucleic Acids Res</source><volume>32</volume><comment>(Database Issue)</comment><fpage>D277</fpage><lpage>D280</lpage><year>2004</year><pub-id pub-id-type="doi">10.1093/nar/gkh063</pub-id><pub-id pub-id-type="pmid">14681412</pub-id><pub-id pub-id-type="pmcid">308797</pub-id></element-citation></ref>
<ref id="b29-mmr-18-01-0882"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P</given-names></name><name><surname>Markiel</surname><given-names>A</given-names></name><name><surname>Ozier</surname><given-names>O</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name><name><surname>Wang</surname><given-names>GT</given-names></name><name><surname>Ramage</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Schwikowski</surname><given-names>B</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><article-title>Cytoscape: A software environment for integrated models of biomolecular interaction networks</article-title><source>Genome Res</source><volume>13</volume><fpage>2498</fpage><lpage>2504</lpage><year>2003</year><pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id><pub-id pub-id-type="pmid">14597658</pub-id><pub-id pub-id-type="pmcid">403769</pub-id></element-citation></ref>
<ref id="b30-mmr-18-01-0882"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pujana</surname><given-names>MA</given-names></name><name><surname>Han</surname><given-names>JD</given-names></name><name><surname>Starita</surname><given-names>LM</given-names></name><name><surname>Stevens</surname><given-names>KN</given-names></name><name><surname>Tewari</surname><given-names>M</given-names></name><name><surname>Ahn</surname><given-names>JS</given-names></name><name><surname>Rennert</surname><given-names>G</given-names></name><name><surname>Moreno</surname><given-names>V</given-names></name><name><surname>Kirchhoff</surname><given-names>T</given-names></name><name><surname>Gold</surname><given-names>B</given-names></name><etal/></person-group><article-title>Network modeling links breast cancer susceptibility and centrosome dysfunction</article-title><source>Nat Genet</source><volume>39</volume><fpage>1338</fpage><lpage>1349</lpage><year>2007</year><pub-id pub-id-type="doi">10.1038/ng.2007.2</pub-id><pub-id pub-id-type="pmid">17922014</pub-id></element-citation></ref>
<ref id="b31-mmr-18-01-0882"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravasz</surname><given-names>E</given-names></name><name><surname>Somera</surname><given-names>AL</given-names></name><name><surname>Mongru</surname><given-names>DA</given-names></name><name><surname>Oltvai</surname><given-names>ZN</given-names></name><name><surname>Barab&#x00E1;si</surname><given-names>AL</given-names></name></person-group><article-title>Hierarchical organization of modularity in metabolic networks</article-title><source>Science</source><volume>297</volume><fpage>1551</fpage><lpage>1555</lpage><year>2002</year><pub-id pub-id-type="doi">10.1126/science.1073374</pub-id><pub-id pub-id-type="pmid">12202830</pub-id></element-citation></ref>
<ref id="b32-mmr-18-01-0882"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref>
<ref id="b33-mmr-18-01-0882"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name></person-group><article-title>Matrine suppresses airway inflammation by downregulating SOCS3 expression via inhibition of NF-&#x03BA;B signaling in airway epithelial cells and asthmatic mice</article-title><source>Biochem Biophys Res Commun</source><volume>477</volume><fpage>83</fpage><lpage>90</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2016.06.024</pub-id><pub-id pub-id-type="pmid">27286706</pub-id></element-citation></ref>
<ref id="b34-mmr-18-01-0882"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>CF</given-names></name><name><surname>Liu</surname><given-names>YJ</given-names></name><name><surname>Mao</surname><given-names>YF</given-names></name><name><surname>Lv</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>SY</given-names></name><name><surname>Zhu</surname><given-names>XY</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name></person-group><article-title>Salidroside attenuates ventilation induced lung injury via SIRT1-dependent inhibition of NLRP3 inflammasome</article-title><source>Cell Physiol Biochem</source><volume>42</volume><fpage>34</fpage><lpage>43</lpage><year>2017</year><pub-id pub-id-type="doi">10.1159/000477112</pub-id><pub-id pub-id-type="pmid">28490015</pub-id></element-citation></ref>
<ref id="b35-mmr-18-01-0882"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Meng</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>C</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><etal/></person-group><article-title>Global transcriptome-wide analysis of CIK cells identify distinct roles of IL-2 and IL-15 in acquisition of cytotoxic capacity against tumor</article-title><source>BMC Med Genomics</source><volume>7</volume><fpage>49</fpage><year>2014</year><pub-id pub-id-type="doi">10.1186/1755-8794-7-49</pub-id><pub-id pub-id-type="pmid">25108500</pub-id><pub-id pub-id-type="pmcid">4134122</pub-id></element-citation></ref>
<ref id="b36-mmr-18-01-0882"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>ZW</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>RH</given-names></name><name><surname>Liu</surname><given-names>XM</given-names></name><name><surname>Xu</surname><given-names>FK</given-names></name><name><surname>Zhao</surname><given-names>GY</given-names></name><name><surname>Lu</surname><given-names>CL</given-names></name><name><surname>Ge</surname><given-names>D</given-names></name></person-group><article-title>Genome-wide screening and co-expression network analysis identify recurrence-specific biomarkers of esophageal squamous cell carcinoma</article-title><source>Tumour Biol</source><volume>35</volume><fpage>10959</fpage><lpage>10968</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s13277-014-2388-9</pub-id><pub-id pub-id-type="pmid">25087095</pub-id></element-citation></ref>
<ref id="b37-mmr-18-01-0882"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname><given-names>Y</given-names></name><name><surname>Hochberg</surname><given-names>Y</given-names></name></person-group><article-title>Controlling the false discovery rate: A practical and powerful approach to multiple testing</article-title><source>J R Stat Soc Series B</source><volume>57</volume><fpage>pp289</fpage><lpage>300</lpage><year>1995</year></element-citation></ref>
<ref id="b38-mmr-18-01-0882"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawitan</surname><given-names>Y</given-names></name><name><surname>Michiels</surname><given-names>S</given-names></name><name><surname>Koscielny</surname><given-names>S</given-names></name><name><surname>Gusnanto</surname><given-names>A</given-names></name><name><surname>Ploner</surname><given-names>A</given-names></name></person-group><article-title>False discovery rate, sensitivity and sample size for microarray studies</article-title><source>Bioinformatics</source><volume>21</volume><fpage>3017</fpage><lpage>3024</lpage><year>2005</year><pub-id pub-id-type="doi">10.1093/bioinformatics/bti448</pub-id><pub-id pub-id-type="pmid">15840707</pub-id></element-citation></ref>
<ref id="b39-mmr-18-01-0882"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>SF</given-names></name><name><surname>Grigoryev</surname><given-names>DN</given-names></name><name><surname>Taylor</surname><given-names>AD</given-names></name><name><surname>Nonas</surname><given-names>S</given-names></name><name><surname>Sammani</surname><given-names>S</given-names></name><name><surname>Ye</surname><given-names>SQ</given-names></name><name><surname>Garcia</surname><given-names>JG</given-names></name></person-group><article-title>Bioinformatic identification of novel early stress response genes in rodent models of lung injury</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>289</volume><fpage>L468</fpage><lpage>L477</lpage><year>2005</year><pub-id pub-id-type="doi">10.1152/ajplung.00109.2005</pub-id><pub-id pub-id-type="pmid">15908477</pub-id></element-citation></ref>
<ref id="b40-mmr-18-01-0882"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolinay</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Howrylak</surname><given-names>J</given-names></name><name><surname>Hunninghake</surname><given-names>GM</given-names></name><name><surname>An</surname><given-names>CH</given-names></name><name><surname>Fredenburgh</surname><given-names>L</given-names></name><name><surname>Massaro</surname><given-names>AF</given-names></name><name><surname>Rogers</surname><given-names>A</given-names></name><name><surname>Gazourian</surname><given-names>L</given-names></name><name><surname>Nakahira</surname><given-names>K</given-names></name><etal/></person-group><article-title>Inflammasome-regulated cytokines are critical mediators of acute lung injury</article-title><source>Am J Respir Crit Care Med</source><volume>185</volume><fpage>1225</fpage><lpage>1234</lpage><year>2012</year><pub-id pub-id-type="doi">10.1164/rccm.201201-0003OC</pub-id><pub-id pub-id-type="pmid">22461369</pub-id><pub-id pub-id-type="pmcid">3373064</pub-id></element-citation></ref>
<ref id="b41-mmr-18-01-0882"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirzapoiazova</surname><given-names>T</given-names></name><name><surname>Moitra</surname><given-names>J</given-names></name><name><surname>Moreno-Vinasco</surname><given-names>L</given-names></name><name><surname>Sammani</surname><given-names>S</given-names></name><name><surname>Turner</surname><given-names>JR</given-names></name><name><surname>Chiang</surname><given-names>ET</given-names></name><name><surname>Evenoski</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Singleton</surname><given-names>PA</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Non-muscle myosin light chain kinase isoform is a viable molecular target in acute inflammatory lung injury</article-title><source>Am J Respir Cell Mol Biol</source><volume>44</volume><fpage>40</fpage><lpage>52</lpage><year>2011</year><pub-id pub-id-type="doi">10.1165/rcmb.2009-0197OC</pub-id><pub-id pub-id-type="pmid">20139351</pub-id></element-citation></ref>
<ref id="b42-mmr-18-01-0882"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlig</surname><given-names>U</given-names></name><name><surname>Fehrenbach</surname><given-names>H</given-names></name><name><surname>Lachmann</surname><given-names>RA</given-names></name><name><surname>Goldmann</surname><given-names>T</given-names></name><name><surname>Lachmann</surname><given-names>B</given-names></name><name><surname>Vollmer</surname><given-names>E</given-names></name><name><surname>Uhlig</surname><given-names>S</given-names></name></person-group><article-title>Phosphoinositide 3-OH kinase inhibition prevents ventilation-induced lung cell activation</article-title><source>Am J Respir Crit Care Med</source><volume>169</volume><fpage>201</fpage><lpage>208</lpage><year>2004</year><pub-id pub-id-type="doi">10.1164/rccm.200303-343OC</pub-id><pub-id pub-id-type="pmid">14578214</pub-id></element-citation></ref>
<ref id="b43-mmr-18-01-0882"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanderbilt</surname><given-names>JN</given-names></name><name><surname>Mager</surname><given-names>EM</given-names></name><name><surname>Allen</surname><given-names>L</given-names></name><name><surname>Sawa</surname><given-names>T</given-names></name><name><surname>Wiener-Kronish</surname><given-names>J</given-names></name><name><surname>Gonzalez</surname><given-names>R</given-names></name><name><surname>Dobbs</surname><given-names>LG</given-names></name></person-group><article-title>CXC chemokines and their receptors are expressed in type II cells and upregulated following lung injury</article-title><source>Am J Respir Cell Mol Biol</source><volume>29</volume><fpage>661</fpage><lpage>668</lpage><year>2003</year><pub-id pub-id-type="doi">10.1165/rcmb.2002-0227OC</pub-id><pub-id pub-id-type="pmid">12829448</pub-id></element-citation></ref>
<ref id="b44-mmr-18-01-0882"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakashita</surname><given-names>A</given-names></name><name><surname>Nishimura</surname><given-names>Y</given-names></name><name><surname>Nishiuma</surname><given-names>T</given-names></name><name><surname>Takenaka</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Kotani</surname><given-names>Y</given-names></name><name><surname>Yokoyama</surname><given-names>M</given-names></name></person-group><article-title>Neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury in mice</article-title><source>Eur J Pharmacol</source><volume>571</volume><fpage>62</fpage><lpage>71</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.ejphar.2007.05.053</pub-id><pub-id pub-id-type="pmid">17599828</pub-id></element-citation></ref>
<ref id="b45-mmr-18-01-0882"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammerschmidt</surname><given-names>S</given-names></name><name><surname>Kuhn</surname><given-names>H</given-names></name><name><surname>Grasenack</surname><given-names>T</given-names></name><name><surname>Gessner</surname><given-names>C</given-names></name><name><surname>Wirtz</surname><given-names>H</given-names></name></person-group><article-title>Apoptosis and necrosis induced by cyclic mechanical stretching in alveolar type II cells</article-title><source>Am J Respir Cell Mol Biol</source><volume>30</volume><fpage>396</fpage><lpage>402</lpage><year>2004</year><pub-id pub-id-type="doi">10.1165/rcmb.2003-0136OC</pub-id><pub-id pub-id-type="pmid">12959945</pub-id></element-citation></ref>
<ref id="b46-mmr-18-01-0882"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>LJ</given-names></name><name><surname>Ge</surname><given-names>YL</given-names></name><name><surname>Lin</surname><given-names>SY</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name></person-group><article-title>Preconditioning effects of physiological cyclic stretch on pathologically mechanical stretch-induced alveolar epithelial cell apoptosis and barrier dysfunction</article-title><source>Biochem Biophys Res Commun</source><volume>448</volume><fpage>342</fpage><lpage>348</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2014.03.063</pub-id><pub-id pub-id-type="pmid">24699412</pub-id></element-citation></ref>
<ref id="b47-mmr-18-01-0882"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chess</surname><given-names>PR</given-names></name><name><surname>Benson</surname><given-names>RP</given-names></name><name><surname>Maniscalco</surname><given-names>WM</given-names></name><name><surname>Wright</surname><given-names>TW</given-names></name><name><surname>O&#x0027;Reilly</surname><given-names>MA</given-names></name><name><surname>Johnston</surname><given-names>CJ</given-names></name></person-group><article-title>Murine mechanical ventilation stimulates alveolar epithelial cell proliferation</article-title><source>Exp Lung Res</source><volume>36</volume><fpage>331</fpage><lpage>341</lpage><year>2010</year><pub-id pub-id-type="doi">10.3109/01902141003632332</pub-id><pub-id pub-id-type="pmid">20653468</pub-id><pub-id pub-id-type="pmcid">4342053</pub-id></element-citation></ref>
<ref id="b48-mmr-18-01-0882"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukhopadhyay</surname><given-names>S</given-names></name><name><surname>Hoidal</surname><given-names>JR</given-names></name><name><surname>Mukherjee</surname><given-names>TK</given-names></name></person-group><article-title>Role of TNFalpha in pulmonary pathophysiology</article-title><source>Respir Res</source><volume>7</volume><fpage>125</fpage><year>2006</year><pub-id pub-id-type="doi">10.1186/1465-9921-7-125</pub-id><pub-id pub-id-type="pmid">17034639</pub-id><pub-id pub-id-type="pmcid">1613248</pub-id></element-citation></ref>
<ref id="b49-mmr-18-01-0882"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>MR</given-names></name><name><surname>Takata</surname><given-names>M</given-names></name></person-group><article-title>Inflammatory mechanisms of ventilator-induced lung injury: A time to stop and think?</article-title><source>Anaesthesia</source><volume>68</volume><fpage>175</fpage><lpage>178</lpage><year>2013</year><pub-id pub-id-type="doi">10.1111/anae.12085</pub-id><pub-id pub-id-type="pmid">23173768</pub-id></element-citation></ref>
<ref id="b50-mmr-18-01-0882"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>MR</given-names></name><name><surname>Wakabayashi</surname><given-names>K</given-names></name><name><surname>Bertok</surname><given-names>S</given-names></name><name><surname>Oakley</surname><given-names>CM</given-names></name><name><surname>Patel</surname><given-names>BV</given-names></name><name><surname>O&#x0027;Dea</surname><given-names>KP</given-names></name><name><surname>Cordy</surname><given-names>JC</given-names></name><name><surname>Morley</surname><given-names>PJ</given-names></name><name><surname>Bayliffe</surname><given-names>AI</given-names></name><name><surname>Takata</surname><given-names>M</given-names></name></person-group><article-title>Inhibition of TNF receptor p55 by a domain antibody attenuates the initial phase of acid-induced lung injury in mice</article-title><source>Front Immunol</source><volume>8</volume><fpage>128</fpage><year>2017</year><pub-id pub-id-type="doi">10.3389/fimmu.2017.00128</pub-id><pub-id pub-id-type="pmid">28243236</pub-id><pub-id pub-id-type="pmcid">5304467</pub-id></element-citation></ref>
<ref id="b51-mmr-18-01-0882"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckle</surname><given-names>T</given-names></name><name><surname>Kewley</surname><given-names>EM</given-names></name><name><surname>Brodsky</surname><given-names>KS</given-names></name><name><surname>Tak</surname><given-names>E</given-names></name><name><surname>Bonney</surname><given-names>S</given-names></name><name><surname>Gobel</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>D</given-names></name><name><surname>Glover</surname><given-names>LE</given-names></name><name><surname>Riegel</surname><given-names>AK</given-names></name><name><surname>Colgan</surname><given-names>SP</given-names></name><name><surname>Eltzschig</surname><given-names>HK</given-names></name></person-group><article-title>Identification of hypoxia-inducible factor HIF-1A as transcriptional regulator of the A2B adenosine receptor during acute lung injury</article-title><source>J Immunol</source><volume>192</volume><fpage>1249</fpage><lpage>1256</lpage><year>2014</year><pub-id pub-id-type="doi">10.4049/jimmunol.1100593</pub-id><pub-id pub-id-type="pmid">24391213</pub-id><pub-id pub-id-type="pmcid">3946986</pub-id></element-citation></ref>
<ref id="b52-mmr-18-01-0882"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckle</surname><given-names>T</given-names></name><name><surname>Grenz</surname><given-names>A</given-names></name><name><surname>Laucher</surname><given-names>S</given-names></name><name><surname>Eltzschig</surname><given-names>HK</given-names></name></person-group><article-title>A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice</article-title><source>J Clin Invest</source><volume>118</volume><fpage>3301</fpage><lpage>3315</lpage><year>2008</year><pub-id pub-id-type="pmid">18787641</pub-id><pub-id pub-id-type="pmcid">2532979</pub-id></element-citation></ref>
<ref id="b53-mmr-18-01-0882"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Gross</surname><given-names>C</given-names></name><name><surname>Desai</surname><given-names>AA</given-names></name><name><surname>Zemskov</surname><given-names>E</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Garcia</surname><given-names>AN</given-names></name><name><surname>Jacobson</surname><given-names>JR</given-names></name><name><surname>Yuan</surname><given-names>JX</given-names></name><name><surname>Garcia</surname><given-names>JG</given-names></name><name><surname>Black</surname><given-names>SM</given-names></name></person-group><article-title>Endothelial cell signaling and ventilator-induced lung injury: Molecular mechanisms, genomic analyses, and therapeutic targets</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>312</volume><fpage>L452</fpage><lpage>L476</lpage><year>2017</year><pub-id pub-id-type="doi">10.1152/ajplung.00231.2016</pub-id><pub-id pub-id-type="pmid">27979857</pub-id></element-citation></ref>
<ref id="b54-mmr-18-01-0882"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hert</surname><given-names>DG</given-names></name><name><surname>Fredlake</surname><given-names>CP</given-names></name><name><surname>Barron</surname><given-names>AE</given-names></name></person-group><article-title>Advantages and limitations of next-generation sequencing technologies: A comparison of electrophoresis and non-electrophoresis methods</article-title><source>Electrophoresis</source><volume>29</volume><fpage>4618</fpage><lpage>4626</lpage><year>2008</year><pub-id pub-id-type="doi">10.1002/elps.200800456</pub-id><pub-id pub-id-type="pmid">19053153</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-18-01-0882" position="float">
<label>Figure 1.</label>
<caption><p>Differentially expressed genes between sham and ventilator-induced lung injury groups. The volcano plot includes all of the genes in the two groups. Differentially expressed genes are marked as red dots (FDR&#x003C;0.05), other genes are marked as blue or green dots. Blue dots meant FDR&#x2265;0.05, green dots meant &#x2212;2&#x2264;FC&#x2264;2. FC, fold change; FDR, false discovery rate.</p></caption>
<graphic xlink:href="MMR-18-01-0882-g00.tif"/>
</fig>
<fig id="f2-mmr-18-01-0882" position="float">
<label>Figure 2.</label>
<caption><p>(A) Three lncRNAs (Map2k3os, Dnm3os and Abhd11os) identified by RNA-Seq were verified by RT-qPCR. &#x002A;&#x002A;P&#x003C;0.01 vs. the sham group. (B) Three mRNAs (Gadd45a, Cldn4 and Tbxa2r) identified by RNA-Seq were verified by RT-qPCR. &#x002A;&#x002A;P&#x003C;0.01 vs. the sham group. Abhd11os, abhydrolase domain containing 11, opposite strand; Cldn4, claudin 4; Dnm3os, dynamin 3, opposite strand; Gadd45a, growth arrest and DNA damage-inducible &#x03B1;; lncRNA, long non-coding RNA; Map2k3os, mitogen-activated protein kinase kinase 3, opposite strand; RNA-Seq, RNA-sequencing; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; Tbxa2r, thromboxane A2 receptor.</p></caption>
<graphic xlink:href="MMR-18-01-0882-g01.tif"/>
</fig>
<fig id="f3-mmr-18-01-0882" position="float">
<label>Figure 3.</label>
<caption><p>GO analysis based on differential genes between sham and ventilator-induced lung injury groups. (A) Top 15 GO categories for upregulated genes. (B) Top 15 GO categories for downregulated genes (FDR&#x003C;0.05). FDR, false discovery rate; GO, gene ontology.</p></caption>
<graphic xlink:href="MMR-18-01-0882-g02.tif"/>
</fig>
<fig id="f4-mmr-18-01-0882" position="float">
<label>Figure 4.</label>
<caption><p>Pathway analysis of differentially expressed genes based on the KEGG database. (A) Top 20 signaling pathways, as determined by KEGG. (B) Interactions between the differential signaling pathways (path-act network, a graphical representation of pathways of the interaction of these pathway terms using cytoscape 3.5.1). Red dots represent upregulated pathways, green dots represent downregulated pathways and yellow dots represent bidirectional pathways. KEGG, Kyoto Encyclopedia of Genes and Genomics.</p></caption>
<graphic xlink:href="MMR-18-01-0882-g03.tif"/>
<graphic xlink:href="MMR-18-01-0882-g04.tif"/>
</fig>
<fig id="f5-mmr-18-01-0882" position="float">
<label>Figure 5.</label>
<caption><p>Co-expression network of differential genes in the ventilator-induced lung injury group.</p></caption>
<graphic xlink:href="MMR-18-01-0882-g05.tif"/>
</fig>
<fig id="f6-mmr-18-01-0882" position="float">
<label>Figure 6.</label>
<caption><p>mRNA expression levels of (A) IL-1&#x03B2;, (B) IL-6 and (C) TNF-&#x03B1; in MLE12 cells, as determined by RT-qPCR. Protein level of (D) IL-1&#x03B2;, (E) IL-6 and (F) TNF-&#x03B1; in the culture medium, as determined by ELISA. (n=6). &#x002A;&#x002A;P&#x003C;0.01 compared with control group without cyclic stretch or siRNA. <sup>##</sup>P&#x003C;0.01 compared with control siRNA group. CS, cyclic stretch; IL, interleukin; Map2k3os, mitogen-activated protein kinase kinase 3, opposite strand; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; siRNA, small interfering RNA; TNF, tumor necrosis factor.</p></caption>
<graphic xlink:href="MMR-18-01-0882-g06.tif"/>
</fig>
<table-wrap id="tI-mmr-18-01-0882" position="float">
<label>Table I.</label>
<caption><p>Primers used for the amplification of various genes (long non-coding RNAs and mRNAs) in mouse lung tissues.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Description</th>
<th align="center" valign="bottom">Sequence (5&#x2032;-3&#x2032;)</th>
<th align="center" valign="bottom">Product size (bp)</th>
<th align="center" valign="bottom">Accession no.</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Map2k3os, F</td>
<td align="left" valign="top">AGCAAAGCAACAGCCTCACT</td>
<td align="center" valign="top">1,267</td>
<td align="left" valign="top">NR_027800.1</td>
</tr>
<tr>
<td align="left" valign="top">Map2k3os, R</td>
<td align="left" valign="top">CACGGGCTCTCTGTGCTTAT</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Dnm3os, F</td>
<td align="left" valign="top">GCCTGGCTGGACAGAGTTGT</td>
<td align="center" valign="top">7,928</td>
<td align="left" valign="top">NR_002870.2</td>
</tr>
<tr>
<td align="left" valign="top">Dnm3os, R</td>
<td align="left" valign="top">TCAATGGCTGGTGGTCATTC</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Abhd11os, F</td>
<td align="left" valign="top">CAGTCACCAGGCCTTGACTC</td>
<td align="center" valign="top">519</td>
<td align="left" valign="top">NR_026688.1</td>
</tr>
<tr>
<td align="left" valign="top">Abhd11os, R</td>
<td align="left" valign="top">CGCTTCTTAGCAATGGCTTC</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Gadd45a, F</td>
<td align="left" valign="top">CTGCAGAGCAGAAGACCGAA</td>
<td align="center" valign="top">1,224</td>
<td align="left" valign="top">NM_007836.1</td>
</tr>
<tr>
<td align="left" valign="top">Gadd45a, R</td>
<td align="left" valign="top">GGGTCTACGTTGAGCAGCTT</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Cldn4, F</td>
<td align="left" valign="top">GGCGTCTATGGGACTACAGG</td>
<td align="center" valign="top">1,827</td>
<td align="left" valign="top">NM_009903.2</td>
</tr>
<tr>
<td align="left" valign="top">Cldn4, R</td>
<td align="left" valign="top">GAGCGCACAACTCAGGATG</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Tbxa2r, F</td>
<td align="left" valign="top">GCTCATCTACCTGCGTGTGG</td>
<td align="center" valign="top">1,809</td>
<td align="left" valign="top">NM_001277265.1</td>
</tr>
<tr>
<td align="left" valign="top">Tbxa2r, R</td>
<td align="left" valign="top">CAGCCTGGAGCTGTGAACTG</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x03B2;-actin, F</td>
<td align="left" valign="top">CTGTATGCCTCTGGTCGTAC</td>
<td align="center" valign="top">214</td>
<td align="left" valign="top">NM_007393.3</td>
</tr>
<tr>
<td align="left" valign="top">&#x03B2;-actin, R</td>
<td align="left" valign="top">TGATGTCACGCACGATTTCC</td>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-mmr-18-01-0882"><p>Abhd11os, abhydrolase domain containing 11, opposite strand; Cldn4, claudin 4; Dnm3os, dynamin 3, opposite strand; F, forward; Gadd45a, growth arrest and DNA damage-inducible &#x03B1;; Map2k3os, mitogen-activated protein kinase kinase 3, opposite strand; R, reverse; Tbxa2r, thromboxane A2 receptor.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-mmr-18-01-0882" position="float">
<label>Table II.</label>
<caption><p>Top 20 differentially expressed lncRNAs (10 upregulated and 10 downregulated lncRNAs) between ventilator-induced lung injury group and sham group.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">AccID</th>
<th align="center" valign="bottom">FDR</th>
<th align="center" valign="bottom">Regulation</th>
<th align="center" valign="bottom">Location</th>
<th align="center" valign="bottom">Description</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Gm4610</td>
<td align="center" valign="top">9.71&#x00D7;10<sup>&#x2212;27</sup></td>
<td align="left" valign="top">Up</td>
<td align="left" valign="top">chr3</td>
<td align="left" valign="top">Predicted gene 4610</td>
</tr>
<tr>
<td align="left" valign="top">LOC102636324</td>
<td align="center" valign="top">1.55&#x00D7;10<sup>&#x2212;16</sup></td>
<td align="left" valign="top">Up</td>
<td align="left" valign="top">chr13</td>
<td align="left" valign="top">Uncharacterized LOC102636324</td>
</tr>
<tr>
<td align="left" valign="top">Gm11827</td>
<td align="center" valign="top">2.74&#x00D7;10<sup>&#x2212;15</sup></td>
<td align="left" valign="top">Up</td>
<td align="left" valign="top">chr4</td>
<td align="left" valign="top">Predicted gene 11827</td>
</tr>
<tr>
<td align="left" valign="top">LOC101056163</td>
<td align="center" valign="top">1.01&#x00D7;10<sup>&#x2212;12</sup></td>
<td align="left" valign="top">Up</td>
<td align="left" valign="top">chr8</td>
<td align="left" valign="top">14-3-3 protein sigma-like</td>
</tr>
<tr>
<td align="left" valign="top">Gm5582</td>
<td align="center" valign="top">3.60&#x00D7;10<sup>&#x2212;12</sup></td>
<td align="left" valign="top">Up</td>
<td align="left" valign="top">chr6</td>
<td align="left" valign="top">Predicted gene 5582</td>
</tr>
<tr>
<td align="left" valign="top">Serpina3h</td>
<td align="center" valign="top">5.07&#x00D7;10<sup>&#x2212;12</sup></td>
<td align="left" valign="top">Up</td>
<td align="left" valign="top">chr12</td>
<td align="left" valign="top">Serpina3h protein</td>
</tr>
<tr>
<td align="left" valign="top">Krt8-ps</td>
<td align="center" valign="top">9.79&#x00D7;10<sup>&#x2212;10</sup></td>
<td align="left" valign="top">Up</td>
<td align="left" valign="top">chr7</td>
<td align="left" valign="top">Keratin 8, pseudogene</td>
</tr>
<tr>
<td align="left" valign="top">Gm9523</td>
<td align="center" valign="top">4.19&#x00D7;10<sup>&#x2212;9</sup></td>
<td align="left" valign="top">Up</td>
<td align="left" valign="top">chr5</td>
<td align="left" valign="top">Methionine adenosyltransferase II, alpha pseudogene</td>
</tr>
<tr>
<td align="left" valign="top">LOC102633421</td>
<td align="center" valign="top">9.00&#x00D7;10<sup>&#x2212;9</sup></td>
<td align="left" valign="top">Up</td>
<td align="left" valign="top">chr11</td>
<td align="left" valign="top">14-3-3 protein sigma-like</td>
</tr>
<tr>
<td align="left" valign="top">Mir22hg</td>
<td align="center" valign="top">3.83&#x00D7;10<sup>&#x2212;8</sup></td>
<td align="left" valign="top">Up</td>
<td align="left" valign="top">chr11</td>
<td align="left" valign="top">Mir22 host gene (non-protein coding)</td>
</tr>
<tr>
<td align="left" valign="top">Gm16119</td>
<td align="center" valign="top">3.98&#x00D7;10<sup>&#x2212;8</sup></td>
<td align="left" valign="top">Down</td>
<td align="left" valign="top">chr2</td>
<td align="left" valign="top">Uridine-cytidine kinase 1-like 1, opposite strand</td>
</tr>
<tr>
<td align="left" valign="top">LOC102632993</td>
<td align="center" valign="top">6.82&#x00D7;10<sup>&#x2212;8</sup></td>
<td align="left" valign="top">Down</td>
<td align="left" valign="top">chr7</td>
<td align="left" valign="top">Uncharacterized LOC102632993</td>
</tr>
<tr>
<td align="left" valign="top">LOC102635638</td>
<td align="center" valign="top">4.02&#x00D7;10<sup>&#x2212;7</sup></td>
<td align="left" valign="top">Down</td>
<td align="left" valign="top">chr9</td>
<td align="left" valign="top">Uncharacterized LOC102635638</td>
</tr>
<tr>
<td align="left" valign="top">9630028I04Rik</td>
<td align="center" valign="top">8.16&#x00D7;10<sup>&#x2212;7</sup></td>
<td align="left" valign="top">Down</td>
<td align="left" valign="top">chr17</td>
<td align="left" valign="top">RIKEN cDNA 9630028I04 gene</td>
</tr>
<tr>
<td align="left" valign="top">A330009N23Rik</td>
<td align="center" valign="top">4.05&#x00D7;10<sup>&#x2212;6</sup></td>
<td align="left" valign="top">Down</td>
<td align="left" valign="top">chr15</td>
<td align="left" valign="top">RIKEN cDNA A330009N23 gene</td>
</tr>
<tr>
<td align="left" valign="top">AI197445</td>
<td align="center" valign="top">3.76&#x00D7;10<sup>&#x2212;5</sup></td>
<td align="left" valign="top">Down</td>
<td align="left" valign="top">chr13</td>
<td align="left" valign="top">Expressed sequence AI197445</td>
</tr>
<tr>
<td align="left" valign="top">D930048N14Rik</td>
<td align="center" valign="top">1.05&#x00D7;10<sup>&#x2212;4</sup></td>
<td align="left" valign="top">Down</td>
<td align="left" valign="top">chr11</td>
<td align="left" valign="top">Protein D930048N14Rik</td>
</tr>
<tr>
<td align="left" valign="top">Panct2</td>
<td align="center" valign="top">1.57&#x00D7;10<sup>&#x2212;4</sup></td>
<td align="left" valign="top">Down</td>
<td align="left" valign="top">chr1</td>
<td align="left" valign="top">Pluripotency-associated noncoding transcript 2</td>
</tr>
<tr>
<td align="left" valign="top">5930430L01Rik</td>
<td align="center" valign="top">3.56&#x00D7;10<sup>&#x2212;4</sup></td>
<td align="left" valign="top">Down</td>
<td align="left" valign="top">chr5</td>
<td align="left" valign="top">Katanin p60 ATPase-containing subunit A-like 1</td>
</tr>
<tr>
<td align="left" valign="top">2610507I01Rik</td>
<td align="center" valign="top">5.23&#x00D7;10<sup>&#x2212;4</sup></td>
<td align="left" valign="top">Down</td>
<td align="left" valign="top">chr11</td>
<td align="left" valign="top">RIKEN cDNA 2610507I01 gene</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn2-mmr-18-01-0882"><p>FDR, false discovery rate.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIII-mmr-18-01-0882" position="float">
<label>Table III.</label>
<caption><p>Top 20 differentially expressed long non-coding RNAs in the gene co-expression network.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">AccID</th>
<th align="center" valign="bottom">DifKcore</th>
<th align="center" valign="bottom">DifDegree</th>
<th align="center" valign="bottom">Description</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">D930048N14Rik</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">19</td>
<td align="left" valign="top">Protein D930048N14Rik</td>
</tr>
<tr>
<td align="left" valign="top">Gm10872</td>
<td align="center" valign="top">9</td>
<td align="center" valign="top">14</td>
<td align="left" valign="top">predicted gene 10872</td>
</tr>
<tr>
<td align="left" valign="top">E230013L22Rik</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">19</td>
<td align="left" valign="top">RIKEN cDNA E230013L22 gene</td>
</tr>
<tr>
<td align="left" valign="top">Gm11827</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">13</td>
<td align="left" valign="top">predicted gene 11827</td>
</tr>
<tr>
<td align="left" valign="top">4933407K13Rik</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">19</td>
<td align="left" valign="top">RIKEN cDNA 4933407K13 gene</td>
</tr>
<tr>
<td align="left" valign="top">3010003L21Rik</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">17</td>
<td align="left" valign="top">RIKEN cDNA 3010003L21 gene</td>
</tr>
<tr>
<td align="left" valign="top">A330009N23Rik</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">17</td>
<td align="left" valign="top">RIKEN cDNA A330009N23 gene</td>
</tr>
<tr>
<td align="left" valign="top">B130024G19Rik</td>
<td align="center" valign="top">7</td>
<td align="center" valign="top">14</td>
<td align="left" valign="top">Putative uncharacterized protein</td>
</tr>
<tr>
<td align="left" valign="top">Panct2</td>
<td align="center" valign="top">7</td>
<td align="center" valign="top">10</td>
<td align="left" valign="top">Pluripotency-associated noncoding transcript 2</td>
</tr>
<tr>
<td align="left" valign="top">Chd3os</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">4</td>
<td align="left" valign="top">Putative uncharacterized protein RNF21</td>
</tr>
<tr>
<td align="left" valign="top">AI197445</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">4</td>
<td align="left" valign="top">Expressed sequence AI197445</td>
</tr>
<tr>
<td align="left" valign="top">Ywhaq-ps</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">6</td>
<td align="left" valign="top">Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide, pseudogene 1</td>
</tr>
<tr>
<td align="left" valign="top">9630028I04Rik</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">6</td>
<td align="left" valign="top">RIKEN cDNA 9630028I04 gene</td>
</tr>
<tr>
<td align="left" valign="top">LOC102635838</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">6</td>
<td align="left" valign="top">Uncharacterized LOC102635838</td>
</tr>
<tr>
<td align="left" valign="top">Snhg12</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">3</td>
<td align="left" valign="top">Small nucleolar RNA host gene 12</td>
</tr>
<tr>
<td align="left" valign="top">Map2k3os</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">6</td>
<td align="left" valign="top">Mitogen-activated protein kinase kinase 3, opposite strand</td>
</tr>
<tr>
<td align="left" valign="top">4930481A15Rik</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">2</td>
<td align="left" valign="top">MCG1045479, isoform CRA_b</td>
</tr>
<tr>
<td align="left" valign="top">1810006J02Rik</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">3</td>
<td align="left" valign="top">RIKEN cDNA 1810006J02 gene</td>
</tr>
<tr>
<td align="left" valign="top">LOC102632993</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">1</td>
<td align="left" valign="top">Uncharacterized LOC102632993</td>
</tr>
<tr>
<td align="left" valign="top">LOC102637368</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">1</td>
<td align="left" valign="top">Uncharacterized LOC102637368</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn3-mmr-18-01-0882"><p>DifDegree, differential degree; DifKcore, differential key core.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIV-mmr-18-01-0882" position="float">
<label>Table IV.</label>
<caption><p>Effects of siRNA on long non-coding RNA Map2k3os expression in MLE12 cells (n=4).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Group</th>
<th align="center" valign="bottom">Relative expression</th>
<th align="center" valign="bottom">Relative reduction (&#x0025;)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Control siRNA</td>
<td align="center" valign="top">1&#x00B1;0.184</td>
<td align="center" valign="top">&#x00A0;&#x00A0;0</td>
</tr>
<tr>
<td align="left" valign="top">Map2k3os siRNA</td>
<td align="center" valign="top">0.106&#x00B1;0.042<sup><xref rid="tfn5-mmr-18-01-0882" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">89</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn4-mmr-18-01-0882"><p>Map2k3os, mitogen-activated protein kinase kinase 3, opposite strand; siRNA, small interfering RNA. Data is presented as the mean &#x00B1; standard error.</p></fn>
<fn id="tfn5-mmr-18-01-0882"><label>a</label><p>P&#x003C;0.01 compared with control siRNA group.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>